UK markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
102.34+1.90 (+1.89%)
At close: 4:00PM EDT
102.34 0.00 (0.00%)
After hours: 04:40PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5225.91B
Enterprise value 3223.82B
Trailing P/E 33.05
Forward P/E 129.50
PEG ratio (5-yr expected) 13.67
Price/sales (ttm)11.30
Price/book (mrq)22.09
Enterprise value/revenue 31.72
Enterprise value/EBITDA 73.67

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 344.59%
S&P500 52-week change 330.48%
52-week high 3107.24
52-week low 363.22
50-day moving average 399.59
200-day moving average 387.93

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 3717.3k
Shares outstanding 52.29B
Implied shares outstanding 6N/A
Float 81.64B
% held by insiders 10.01%
% held by institutions 17.70%
Shares short (29 Sept 2021) 42.36M
Short ratio (29 Sept 2021) 42.31
Short % of float (29 Sept 2021) 4N/A
Short % of shares outstanding (29 Sept 2021) 40.10%
Shares short (prior month 30 Aug 2021) 43.46M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 41.47%
Trailing annual dividend rate 39.35
Trailing annual dividend yield 39.31%
5-year average dividend yield 42.42
Payout ratio 447.46%
Dividend date 324 Aug 2021
Ex-dividend date 415 Aug 2021
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 34.15%
Operating margin (ttm)41.64%

Management effectiveness

Return on assets (ttm)22.98%
Return on equity (ttm)70.63%

Income statement

Revenue (ttm)129.91B
Revenue per share (ttm)56.11
Quarterly revenue growth (yoy)10.10%
Gross profit (ttm)106.01B
EBITDA 58.76B
Net income avi to common (ttm)44.36B
Diluted EPS (ttm)2.98
Quarterly earnings growth (yoy)14.10%

Balance sheet

Total cash (mrq)27.22B
Total cash per share (mrq)11.83
Total debt (mrq)13.76B
Total debt/equity (mrq)21.00
Current ratio (mrq)1.06
Book value per share (mrq)28.49

Cash flow statement

Operating cash flow (ttm)54.19B
Levered free cash flow (ttm)22.04B